Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

434.82
-15.2100-3.38%
Post-market: 430.30-4.5200-1.04%16:53 EDT
Volume:4.00M
Turnover:1.75B
Market Cap:111.78B
PE:-113.19
High:449.00
Open:447.52
Low:432.29
Close:450.03
Loading ...

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Zacks
·
11 Apr

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
11 Apr

Analysts’ Top Technology Picks: Microsoft (MSFT), Vertex (VERX)

TIPRANKS
·
10 Apr

Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives

GlobeNewswire
·
10 Apr

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Motley Fool
·
10 Apr

Vertex Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
10 Apr

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-04-09

Reuters
·
10 Apr

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Motley Fool
·
09 Apr

Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $462 From $459, Keeps Equalweight Rating

MT Newswires Live
·
09 Apr

Morgan Stanley Remains a Hold on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
09 Apr

Vertex Pharmaceuticals price target raised to $462 from $459 at Morgan Stanley

TIPRANKS
·
09 Apr

NetApp Partners With Google Cloud to Simplify Scaling High-Performance Workloads in the Cloud

Business Wire
·
09 Apr

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Insider Monkey
·
09 Apr

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

Insider Monkey
·
09 Apr

Is Vertex Pharmaceuticals Stock a Buy?

Motley Fool
·
08 Apr

VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe

Zacks
·
08 Apr

Press Release: Vertex to Announce First Quarter 2025 Financial Results on May 5th

Dow Jones
·
08 Apr

Vertex Pharmaceuticals Says EU Approves Kaftrio Label Expansion in Cystic Fibrosis

MT Newswires Live
·
08 Apr

Vertex Pharmaceuticals announces EC approval of expanded KAFTRIO label

TIPRANKS
·
08 Apr

European Commission Approves Expanded Label for Kaftrio® in Combination With Ivacaftor for People With Cystic Fibrosis

THOMSON REUTERS
·
08 Apr